Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picotamide crossover study for migraine with aura prophylaxis
2011-006207-36Phase 2Completed
- Sponsor
- Proreo Pharma
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Picotamide in migraine with aura (2 arms), sponsored by Proreo Pharma. Primary endpoint: Reduction in number of auras. Started Aug 2012; status: completed.
02
Drugs
Picotamide
03
Conditions
migraine with aura
Beyond the preview
Go deeper on 2011-006207-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006207-36.